Journal of General Virology, Vol 78, 1007-1016, Copyright © 1997 by Society for General Microbiology

ARTICLES

AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro

B Macchi, I Faraoni, J Zhang, S Grelli, C Favalli, A Mastino and E Bonmassar
Department of Experimental Medicine and Biochemical Sciences, University of Rome, Tor Vergata, Italy.

The effect of 3'-azido-3'-deoxythymidine (AZT) on in vitro infection of peripheral blood mononuclear cells (PBMCs) isolated from normal adult individuals with human T cell leukaemia/lymphoma virus type I (HTLV-I) was evaluated. Different PBMC samples were exposed to HTLV-I by cocultivation with MT-2 (a chronically infected cell line) in the presence of 20 U/ml of human recombinant interleukin 2 (IL-2) and graded concentrations of AZT. Control and drug-treated cultures, of both infected and uninfected PBMCs, were then grown for several weeks and monitored for virological and immunological parameters. The results showed a concentration-dependent anti-proliferative effect of AZT in both infected and non-infected cultures. Production of both proviral DNA and viral RNA was inhibited not only at the higher concentrations of AZT (8 microM and 32 microM) but also at concentrations as low as 0.1-2 microM. These results were confirmed by PCR and by flow cytometry analysis for the viral core protein p19. Moreover, treatment with AZT resulted in a decreased expression of CD25 in cultures exposed to HTLV- I as well as in non-infected PBMCs. On the other hand, HLA-DR was down- regulated to a greater extent in drug-treated, virus-exposed cultures in comparison with those not infected. No evidence of the antiviral activity of AZT was observed in PBMC cultures already infected by HTLV- I or in MT-2 cells. These findings demonstrate that treatment with AZT, when given at the time of infection with HTLV-I, has a marked protective effect on PBMCs.

This article has been cited by other articles:

				E. Balestrieri, C. Matteucci, A. Ascolani, A. Piperno, R. Romeo, G. Romeo, U. Chiacchio, A. Mastino, and B. Macchi Effect of Phosphonated Carbocyclic 2'-Oxa-3'-Aza-Nucleoside on Human T-Cell Leukemia Virus Type 1 Infection In Vitro Antimicrob. Agents Chemother., January 1, 2008; 52(1): 54 - 64. [Abstract] [Full Text] [PDF]

				M. Shi, X. Wang, E. De Clercq, S. Takao, and M. Baba Selective Inhibition of Porcine Endogenous Retrovirus Replication in Human Cells by Acyclic Nucleoside Phosphonates Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2600 - 2604. [Abstract] [Full Text] [PDF]

				R. Mahieux HTLV-I and AZT: die another day Blood, August 1, 2006; 108(3): 785 - 786. [Full Text] [PDF]

				L. Xie, B. Yamamoto, A. Haoudi, O. J. Semmes, and P. L. Green PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo Blood, March 1, 2006; 107(5): 1980 - 1988. [Abstract] [Full Text] [PDF]

				K. Van den Bulck, A. Decostere, M. Baele, A. Driessen, J.-C. Debongnie, A. Burette, M. Stolte, R. Ducatelle, and F. Haesebrouck Identification of Non-Helicobacter pylori Spiral Organisms in Gastric Samples from Humans, Dogs, and Cats J. Clin. Microbiol., May 1, 2005; 43(5): 2256 - 2260. [Abstract] [Full Text] [PDF]

				B. Macchi, E. Balestrieri, and A. Mastino Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro J. Antimicrob. Chemother., June 1, 2003; 51(6): 1327 - 1330. [Full Text] [PDF]

				E. Balestrieri, G. Forte, C. Matteucci, A. Mastino, and B. Macchi Effect of Lamivudine on Transmission of Human T-Cell Lymphotropic Virus Type 1 to Adult Peripheral Blood Mononuclear Cells In Vitro Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3080 - 3083. [Abstract] [Full Text] [PDF]

				X. Wang, H. Miyake, M. Okamoto, M. Saito, J.-I. Fujisawa, Y. Tanaka, S. Izumo, and M. Baba Inhibition of the Tax-Dependent Human T-Lymphotropic Virus Type I Replication in Persistently Infected Cells by the Fluoroquinolone Derivative K-37 Mol. Pharmacol., June 1, 2002; 61(6): 1359 - 1365. [Abstract] [Full Text] [PDF]

				D. Derse, S. A. Hill, P. A. Lloyd, H.-k. Chung, and B. A. Morse Examining Human T-Lymphotropic Virus Type 1 Infection and Replication by Cell-Free Infection with Recombinant Virus Vectors J. Virol., September 15, 2001; 75(18): 8461 - 8468. [Abstract] [Full Text] [PDF]

				M. Moriuchi and H. Moriuchi A Milk Protein Lactoferrin Enhances Human T Cell Leukemia Virus Type I and Suppresses HIV-1 Infection J. Immunol., March 15, 2001; 166(6): 4231 - 4236. [Abstract] [Full Text] [PDF]

				S. H. Qari, S. Magre, J. G. García-Lerma, A. I. Hussain, Y. Takeuchi, C. Patience, R. A. Weiss, and W. Heneine Susceptibility of the Porcine Endogenous Retrovirus to Reverse Transcriptase and Protease Inhibitors J. Virol., January 15, 2001; 75(2): 1048 - 1053. [Abstract] [Full Text]

				M. Moriuchi, H. Inoue, and H. Moriuchi Reciprocal Interactions between Human T-Lymphotropic Virus Type 1 and Prostaglandins: Implications for Viral Transmission J. Virol., January 1, 2001; 75(1): 192 - 198. [Abstract] [Full Text]

				A. Alvarez-Barrientos, J. Arroyo, R. Canton, C. Nombela, and M. Sanchez-Perez Applications of Flow Cytometry to Clinical Microbiology Clin. Microbiol. Rev., April 1, 2000; 13(2): 167 - 195. [Abstract] [Full Text] [PDF]

				G. P. Taylor, S. E. Hall, S. Navarrete, C. A. Michie, R. Davis, A. D. Witkover, M. Rossor, M. A. Nowak, P. Rudge, E. Matutes, et al. Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy J. Virol., December 1, 1999; 73(12): 10289 - 10295. [Abstract] [Full Text]

				P. Hollsberg Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 308 - 333. [Abstract] [Full Text] [PDF]